Variant report
Variant | esv3386611 |
---|---|
Chromosome Location | chr5:41494995-41498593 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376735741 | chr5:41495001-41495002 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554182587 | chr5:41495037-41495038 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572350032 | chr5:41495085-41495086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546141057 | chr5:41495087-41495088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73081507 | chr5:41495147-41495148 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs370845045 | chr5:41495152-41495153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544060482 | chr5:41495169-41495170 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562252434 | chr5:41495172-41495173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529026051 | chr5:41495197-41495198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547172347 | chr5:41495205-41495206 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs55779563 | chr5:41495220-41495221 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565728057 | chr5:41495222-41495223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188828786 | chr5:41495290-41495291 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537020586 | chr5:41495297-41495298 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550539691 | chr5:41495316-41495317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570351996 | chr5:41495320-41495321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536930543 | chr5:41495323-41495324 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181932296 | chr5:41495340-41495341 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567343658 | chr5:41495346-41495347 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534766094 | chr5:41495361-41495362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553986712 | chr5:41495515-41495516 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142164208 | chr5:41495569-41495570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs151196346 | chr5:41495572-41495573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562247263 | chr5:41495574-41495575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558164194 | chr5:41495586-41495587 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs57706334 | chr5:41495654-41495655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373768247 | chr5:41495670-41495671 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576844646 | chr5:41495676-41495677 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185332185 | chr5:41495680-41495681 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140372554 | chr5:41495691-41495692 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529468418 | chr5:41495703-41495704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190624790 | chr5:41495772-41495773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34782039 | chr5:41495837-41495838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs59751170 | chr5:41495843-41495844 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs182235840 | chr5:41495879-41495880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs202008338 | chr5:41496050-41496051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2876922 | chr5:41496069-41496070 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs550994641 | chr5:41496096-41496097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs58452377 | chr5:41496138-41496139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535826482 | chr5:41496154-41496155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114619909 | chr5:41496165-41496166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548866011 | chr5:41496166-41496167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185255655 | chr5:41496203-41496204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144161915 | chr5:41496221-41496222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553106607 | chr5:41496242-41496243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113942457 | chr5:41496255-41496256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189918756 | chr5:41496266-41496267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141204567 | chr5:41496268-41496269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369551338 | chr5:41496283-41496284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549993077 | chr5:41496290-41496291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hepatocellular carcinoma | 18929564 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:41486200-41497200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr5:41494400-41495200 | Weak transcription | Left Ventricle | heart |
3 | chr5:41494400-41504600 | Weak transcription | Ovary | ovary |
4 | chr5:41494800-41495000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:41494800-41496000 | Enhancers | Fetal Heart | heart |
6 | chr5:41495000-41495400 | Enhancers | Right Ventricle | heart |
7 | chr5:41495000-41495600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:41495200-41495400 | Enhancers | Left Ventricle | heart |
9 | chr5:41495400-41495600 | Weak transcription | Left Ventricle | heart |
10 | chr5:41495600-41495800 | Enhancers | Left Ventricle | heart |
11 | chr5:41495800-41507000 | Weak transcription | Left Ventricle | heart |
12 | chr5:41496000-41497800 | Weak transcription | Fetal Heart | heart |
13 | chr5:41497200-41498400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
14 | chr5:41497800-41504000 | Enhancers | Fetal Heart | heart |
15 | chr5:41498400-41500000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |